BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 28658541)

  • 1. The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis.
    Otsuka A; Nomura T; Rerknimitr P; Seidel JA; Honda T; Kabashima K
    Immunol Rev; 2017 Jul; 278(1):246-262. PubMed ID: 28658541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.
    Werfel T; Allam JP; Biedermann T; Eyerich K; Gilles S; Guttman-Yassky E; Hoetzenecker W; Knol E; Simon HU; Wollenberg A; Bieber T; Lauener R; Schmid-Grendelmeier P; Traidl-Hoffmann C; Akdis CA
    J Allergy Clin Immunol; 2016 Aug; 138(2):336-49. PubMed ID: 27497276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The research for atopic dermatitis: up to date].
    Yokozeki H
    Nihon Rinsho; 2014 Aug; 72(8):1503-9. PubMed ID: 25167760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms.
    Liang Y; Chang C; Lu Q
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):315-328. PubMed ID: 26385242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of IL-13Rα2 in atopic skin inflammation.
    Furue M; Ulzii D; Nakahara T; Tsuji G; Furue K; Hashimoto-Hachiya A; Kido-Nakahara M
    Allergol Int; 2020 Jul; 69(3):412-416. PubMed ID: 32037147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity.
    Kabashima K
    J Dermatol Sci; 2013 Apr; 70(1):3-11. PubMed ID: 23473856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.
    Skabytska Y; Kaesler S; Volz T; Biedermann T
    Semin Immunopathol; 2016 Jan; 38(1):29-43. PubMed ID: 26573298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis.
    Nakashima C; Otsuka A; Kabashima K
    Exp Dermatol; 2018 Apr; 27(4):327-331. PubMed ID: 29524262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bee Venom Phospholipase A2 Ameliorates House Dust Mite Extract Induced Atopic Dermatitis Like Skin Lesions in Mice.
    Jung KH; Baek H; Kang M; Kim N; Lee SY; Bae H
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β.
    Schwartz C; Moran T; Saunders SP; Kaszlikowska A; Floudas A; Bom J; Nunez G; Iwakura Y; O'Neill L; Irvine AD; McKenzie ANJ; Ogg G; Walsh PT; Demengeot J; Fallon PG
    Allergy; 2019 Oct; 74(10):1920-1933. PubMed ID: 30937919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells and basophils in cutaneous immune responses.
    Otsuka A; Kabashima K
    Allergy; 2015 Feb; 70(2):131-40. PubMed ID: 25250718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis.
    Furue M; Yamamura K; Kido-Nakahara M; Nakahara T; Fukui Y
    Allergy; 2018 Jan; 73(1):29-36. PubMed ID: 28670717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
    Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
    Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-33 in atopic dermatitis.
    Imai Y
    J Dermatol Sci; 2019 Oct; 96(1):2-7. PubMed ID: 31455506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis.
    Mashiko S; Mehta H; Bissonnette R; Sarfati M
    J Dermatol Sci; 2017 Nov; 88(2):167-174. PubMed ID: 28743611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiopathogenesis of atopic dermatitis--an overview.
    Pastar Z; Lipozencić J; Ljubojević S
    Acta Dermatovenerol Croat; 2005; 13(1):54-62. PubMed ID: 15788148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis.
    Yang G; Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu.
    Niebuhr M; Baumert K; Heratizadeh A; Satzger I; Werfel T
    Allergy; 2014 Aug; 69(8):1058-67. PubMed ID: 24894535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Expression of Bacterial Pattern Recognition Receptor NOD2 of Basophils and Microbicidal Peptides in Atopic Dermatitis.
    Wong CK; Chu IM; Hon KL; Tsang MS; Lam CW
    Molecules; 2016 Apr; 21(4):471. PubMed ID: 27077833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts.
    Guttman-Yassky E; Nograles KE; Krueger JG
    J Allergy Clin Immunol; 2011 Jun; 127(6):1420-32. PubMed ID: 21419481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.